Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers

Science Translational Medicine

Volumn 10, Issue 433, 2018, Pages

  Wang, Yuxuan ^a   Li, Lu ^a   Douville, Christopher ^a   Cohen, Joshua D ^a,b   Yen, Ting Tai ^b   Kinde, Isaac ^c   Sundfelt, Karin ^d   Kjær, Susanne K ^e,f   Hruban, Ralph H ^b   Shih, Ie Ming ^b   Wang, Tian Li ^b   Kurman, Robert J ^b   Springer, Simeon ^a   Ptak, Janine ^a   Popoli, Maria ^a   Schaefer, Joy ^a   Silliman, Natalie ^a   Dobbyn, Lisa ^a   Tanner, Edward J ^b   Angarita, Ana ^b   Lycke, Maria ^d   Jochumsen, Kirsten ^g   Afsari, Bahman ^a   Danilova, Ludmila ^a   Levine, Douglas A ^h   Jardon, Kris ⁱ   Zeng, Xing ⁱ   Arseneau, Jocelyne ⁱ   Fu, Lili ⁱ   Diaz, Luis A ^a   Karchin, Rachel ^j   Tomasetti, Cristian ^a   Kinzler, Kenneth W ^a   Vogelstein, Bert ^a,k   Fader, Amanda N ^b   Gilbert, Lucy ⁱ   Papadopoulos, Nickolas ^a   more..

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PapGene Inc   (United States)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

^e University of Copenhagen   (Denmark)

^f DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^g ODENSE UNIVERSITY HOSPITAL   (Denmark)

^h NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

ⁱ MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^j Johns Hopkins University   (United States)

^k HOWARD HUGHES MEDICAL INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CIRCULATING TUMOR DNA;

ADOLESCENT; ADULT; AGED; ANEUPLOIDY; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CONTROLLED STUDY; ENDOMETRIUM CANCER; FEMALE; GENE SEQUENCE; HUMAN; HUMAN TISSUE; LIMIT OF QUANTITATION; LIQUID BIOPSY; MAJOR CLINICAL STUDY; MULTIPLEX POLYMERASE CHAIN REACTION; OVARY CANCER; PAPANICOLAOU TEST; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SOMATIC MUTATION; ENDOMETRIUM TUMOR; MIDDLE AGED; OVARY TUMOR; PROCEDURES; VAGINA SMEAR; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; LIQUID BIOPSY; MIDDLE AGED; OVARIAN NEOPLASMS; PAPANICOLAOU TEST; RETROSPECTIVE STUDIES; VAGINAL SMEARS; YOUNG ADULT;

EID: 85044537049     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.aap8793     Document Type: Article

References (57)

1. L. Geldenhuys, M. L. Murray, Sensitivity and specificity of the Pap smear for glandular lesions of the cervix and endometrium. Acta Cytol. 51, 47-50 (2007).
2. A. B. Ng, J. W. Reagan, S. Hawliczek, B. W. Wentz, Significance of endometrial cells in the detection of endometrial carcinoma and its precursors. Acta Cytol. 18, 356-361 (1974).
3. P. F. Schnatz, M. Guile, D. M. O'Sullivan, J. I. Sorosky, Clinical significance of atypical glandular cells on cervical cytology. Obstet. Gynecol. 107, 701-708 (2006).
4. C. Zhao, A. Florea, A. Onisko, R. M. Austin, Histologic follow-up results in 662 patients with Pap test findings of atypical glandular cells: Results from a large academic womens hospital laboratory employing sensitive screening methods. Gynecol. Oncol. 114, 383-389 (2009).
5. N. Howlader, A. M. Noone, M. Krapcho, D. Miller, K. Bishop, S. F. Altekruse, C. L. Kosary, M. Yu, J. Ruhl, Z. Tatalovich, A. Mariotto, D. R. Lewis, H. S. Chen, E. J. Feuer, K. A. Cronin, SEER Cancer Statistics Review, 1975-2014 (National Cancer Institute, 2017).
6. R. J. Kurman, I.-M. Shih, The origin and pathogenesis of epithelial ovarian cancer: A proposed unifying theory. Am. J. Surg. Pathol. 34, 433-443 (2010).
7. K. N. Moore, A. N. Fader, Uterine papillary serous carcinoma. Clin. Obstet. Gynecol. 54, 278-291 (2011).
8. M. Arnold, N. Pandeya, G. Byrnes, A. G. Renehan, G. A. Stevens, M. Ezzati, J. Ferlay, J. J. Miranda, I. Romieu, R. Dikshit, D. Forman, I. Soerjomataram, Global burden of cancer attributable to high body-mass index in 2012: A population-based study. Lancet Oncol. 16, 36-46 (2015).
9. L. Rahib, B. D. Smith, R. Aizenberg, A. B. Rosenzweig, J. M. Fleshman, L. M. Matrisian, Projecting cancer incidence and deaths to 2030: The unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 74, 2913-2921 (2014).
10. I. Jacobs, A. Gentry-Maharaj, M. Burnell, R. Manchanda, N. Singh, A. Sharma, A. Ryan, M. W. Seif, N. N. Amso, G. Turner, C. Brunell, G. Fletcher, R. Rangar, K. Ford, K. Godfrey, A. Lopes, D. Oram, J. Herod, K. Williamson, I. Scott, H. Jenkins, T. Mould, R. Woolas, J. Murdoch, S. Dobbs, S. Leeson, D. Cruickshank, S. J. Skates, L. Fallowfield, M. Parmar, S. Campbell, U. Menon, Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: A case-control study within the UKCTOCS cohort. Lancet Oncol. 12, 38-48 (2011).
11. S. S. Buys, E. Partridge, A. Black, C. C. Johnson, L. Lamerato, C. Isaacs, D. J. Reding, R. T. Greenlee, L. A. Yokochi, B. Kessel, E. D. Crawford, T. R. Church, G. L. Andriole, J. L. Weissfeld, M. N. Fouad, D. Chia, B. O'Brien, L. R. Ragard, J. D. Clapp, J. M. Rathmell, T. L. Riley, P. Hartge, P. F. Pinsky, C. S. Zhu, G. Izmirlian, B. S. Kramer, A. B. Miller, J. L. Xu, P. C. Prorok, J. K. Gohagan, C. D. Berg; PLCO Project Team, Effect of screening on ovarian cancer mortality: The Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening randomized controlled trial. JAMA 305, 2295-2303 (2011).
12. H. Kobayashi, Y. Yamada, T. Sado, M. Sakata, S. Yoshida, R. Kawaguchi, S. Kanayama, H. Shigetomi, S. Haruta, Y. Tsuji, S. Ueda, T. Kitanaka, A randomized study of screening for ovarian cancer: A multicenter study in Japan. Int. J. Gynecol. Cancer 18, 414-420 (2008).
13. I. J. Jacobs, U. Menon, A. Ryan, A. Gentry-Maharaj, M. Burnell, J. K. Kalsi, N. N. Amso, S. Apostolidou, E. Benjamin, D. Cruickshank, D. N. Crump, S. K. Davies, A. Dawnay, S. Dobbs, G. Fletcher, J. Ford, K. Godfrey, R. Gunu, M. Habib, R. Hallett, J. Herod, H. Jenkins, C. Karpinskyj, S. Leeson, S. J. Lewis, W. R. Liston, A. Lopes, T. Mould, J. Murdoch, D. Oram, D. J. Rabideau, K. Reynolds, I. Scott, M. W. Seif, A. Sharma, N. Singh, J. Taylor, F. Warburton, M. Widschwendter, K. Williamson, R. Woolas, L. Fallowfield, A. J. McGuire, S. Campbell, M. Parmar, S. J. Skates, Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): A randomised controlled trial. Lancet 387, 945-956 (2016).
14. U. Menon, A. Ryan, J. Kalsi, A. Gentry-Maharaj, A. Dawnay, M. Habib, S. Apostolidou, N. Singh, E. Benjamin, M. Burnell, S. Davies, A. Sharma, R. Gunu, K. Godfrey, A. Lopes, D. Oram, J. Herod, K. Williamson, M. W. Seif, H. Jenkins, T. Mould, R. Woolas, J. B. Murdoch, S. Dobbs, N. N. Amso, S. Leeson, D. Cruickshank, I. Scott, L. Fallowfield, M. Widschwendter, K. Reynolds, A. McGuire, S. Campbell, M. Parmar, S. J. Skates, I. Jacobs, Risk algorithm using serial biomarker measurements doubles the number of screen-detected cancers compared with a single-threshold rule in the united kingdom collaborative trial of ovarian cancer screening. J. Clin. Oncol. 33, 2062-2071 (2015).
15. V. A. Moyer; U.S. Preventive Services Task Force., Screening for ovarian cancer: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann. Intern. Med. 157, 900-904 (2012).
16. R. J. Kurman, I. M. Shih, Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer-Shifting the paradigm. Hum. Pathol. 42, 918-931 (2011).
17. Y. Lee, A. Miron, R. Drapkin, M. R. Nucci, F. Medeiros, A. Saleemuddin, J. Garber, C. Birch, H. Mou, R. W. Gordon, D. W. Cramer, F. D. McKeon, C. P. Crum, A candidate precursor to serous carcinoma that originates in the distal fallopian tube. J. Pathol. 211, 26-35 (2007).
18. M. A. Eckert, S. Pan, K. M. Hernandez, R. M. Loth, J. Andrade, S. L. Volchenboum, P. Faber, A. Montag, R. Lastra, M. E. Peter, S. D. Yamada, E. Lengyel, Genomics of ovarian cancer progression reveals diverse metastatic trajectories including intraepithelial metastasis to the fallopian tube. Cancer Discov. 6, 1342-1351 (2016).
19. A. M. Karst, K. Levanon, R. Drapkin, Modeling high-grade serous ovarian carcinogenesis from the fallopian tube. Proc. Natl. Acad. Sci. U.S.A. 108, 7547-7552 (2011).
20. Y. Zhai, R. Wu, R. Kuick, M. S. Sessine, S. Schulman, M. Green, E. R. Fearon, K. R. Cho, High-grade serous carcinomas arise in the mouse oviduct via defects linked to the human disease. J. Pathol. 243, 16-25 (2017).
21. R. J. Kurman, I.-M. Shih, The dualistic model of ovarian carcinogenesis: Revisited, revised, and expanded. Am. J. Pathol. 186, 733-747 (2016).
22. L. Gilbert, O. Basso, J. Sampalis, I. Karp, C. Martins, J. Feng, S. Piedimonte, L. Quintal, A. V. Ramanakumar, J. Takefman, M. S. Grigorie, G. Artho, S. Krishnamurthy; DOvE Study Group, Assessment of symptomatic women for early diagnosis of ovarian cancer: Results from the prospective DOvE pilot project. Lancet Oncol. 13, 285-291 (2012).
23. H. Meden, A. Fattahi-Meibodi, CA 125 in benign gynecological conditions. Int. J. Biol. Markers 13, 231-237 (1998).
24. B. K. Erickson, I. Kinde, Z. C. Dobbin, Y. Wang, J. Y. Martin, R. D. Alvarez, M. G. Conner, W. K. Huh, R. B. S. Roden, K. W. Kinzler, N. Papadopoulos, B. Vogelstein, L. A. Diaz Jr., C. N. Landen Jr., Detection of somatic TP53 mutations in tampons of patients with high-grade serous ovarian cancer. Obstet. Gynecol. 124, 881-885 (2014).
25. I. Kinde, C. Bettegowda, Y. Wang, J. Wu, N. Agrawal, I. M. Shih, R. Kurman, F. Dao, D. A. Levine, R. Giuntoli, R. Roden, J. R. Eshleman, J. P. Carvalho, S. K. Marie, N. Papadopoulos, K. W. Kinzler, B. Vogelstein, L. A. Diaz Jr., Evaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancers. Sci. Transl. Med. 5, 167ra4 (2013).
26. Y. Wang, S. Springer, C. L. Mulvey, N. Silliman, J. Schaefer, M. Sausen, N. James, E. M. Rettig, T. Guo, C. R. Pickering, J. A. Bishop, C. H. Chung, J. A. Califano, D. W. Eisele, C. Fakhry, C. G. Gourin, P. K. Ha, H. Kang, A. Kiess, W. M. Koch, J. N. Myers, H. Quon, J. D. Richmon, D. Sidransky, R. P. Tufano, W. H. Westra, C. Bettegowda, L. A. Diaz Jr., N. Papadopoulos, K. W. Kinzler, B. Vogelstein, N. Agrawal, Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas. Sci. Transl. Med. 7, 293ra104 (2015).
27. I. Kinde, J. Wu, N. Papadopoulos, K. W. Kinzler, B. Vogelstein, Detection and quantification of rare mutations with massively parallel sequencing. Proc. Natl. Acad. Sci. U.S.A. 108, 9530-9535 (2011).
28. Cancer Genome Atlas Research Network, C. Kandoth, N. Schultz, A. D. Cherniack, R. Akbani, Y. Liu, H. Shen, A. G. Robertson, I. Pashtan, R. Shen, C. C. Benz, C. Yau, P. W. Laird, L. Ding, W. Zhang, G. B. Mills, R. Kucherlapati, E. R. Mardis, D. A. Levine, Integrated genomic characterization of endometrial carcinoma. Nature 497, 67-73 (2013).
29. L. W. T. Cheung, B. T. Hennessy, J. Li, S. Yu, A. P. Myers, B. Djordjevic, Y. Lu, K. Stemke-Hale, M. D. Dyer, F. Zhang, Z. Ju, L. C. Cantley, S. E. Scherer, H. Liang, K. H. Lu, R. R. Broaddus, G. B. Mills, High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer elucidates a novel mechanism for regulation of PTEN protein stability. Cancer Discov. 1, 170-185 (2011).
30. Cancer Genome Atlas Research Network., Integrated genomic analyses of ovarian carcinoma. Nature 474, 609-615 (2011).
31. B. Vogelstein, N. Papadopoulos, V. E. Velculescu, S. Zhou, L. A. Diaz Jr., K. W. Kinzler, Cancer genome landscapes. Science 339, 1546-1558 (2013).
32. I. Kinde, N. Papadopoulos, K. W. Kinzler, B. Vogelstein, FAST-SeqS: A simple and efficient method for the detection of aneuploidy by massively parallel sequencing. PLOS ONE 7, e41162 (2012).
33. L. C. Tao, Direct intrauterine sampling: The IUMC endometrial sampler. Diagn. Cytopathol. 17, 153-159 (1997).
34. H. H. J. Wu, K. E. Harshbarger, H. W. Berner, T. M. Elsheikh, Endometrial brush biopsy (Tao brush): Histologic diagnosis of 200 cases with complementary cytology: An accurate sampling technique for the detection of endometrial abnormalities. Am. J. Clin. Pathol. 114, 412-418 (2000).
35. G. Siravegna, S. Marsoni, S. Siena, A. Bardelli, Integrating liquid biopsies into the management of cancer. Nat. Rev. Clin. Oncol. 14, 531-548 (2017).
36. J. D. Cohen, L. Li, Y. Wang, C. Thoburn, B. Afsari, L. Danilova, C. Douville, A. A. Javed, F. Wong, A. Mattox, R. H. Hruban, C. L. Wolfgang, M. G. Goggins, M. Dal Molin, T.-L. Wang, R. Roden, A. P. Klein, J. Ptak, L. Dobbyn, J. Schaefer, N. Silliman, M. Popoli, J. T. Vogelstein, J. D. Browne, R. E. Schoen, R. E. Brand, J. Tie, P. Gibbs, H.-L. Wong, A. S. Mansfield, J. Jen, S. M. Hanash, M. Falconi, P. J. Allen, S. Zhou, C. Bettegowda, L. A. Diaz Jr., C. Tomasetti, K. W. Kinzler, B. Vogelstein, A. M. Lennon, N. Papadopoulos, Detection and localization of surgically resectable cancers with a multi-analyte blood test. Science 359, 926-930 (2018).
37. D. A. Fishman, L. Cohen, S. V. Blank, L. Shulman, D. Singh, K. Bozorgi, R. Tamura, I. Timor-Tritsch, P. E. Schwartz, The role of ultrasound evaluation in the detection of early-stage epithelial ovarian cancer. Am. J. Obstet. Gynecol. 192, 1214-1221 (2005).
38. A. Sharma, S. Apostolidou, M. Burnell, S. Campbell, M. Habib, A. Gentry-Maharaj, N. Amso, M. W. Seif, G. Fletcher, N. Singh, E. Benjamin, C. Brunell, G. Turner, R. Rangar, K. Godfrey, D. Oram, J. Herod, K. Williamson, H. Jenkins, T. Mould, R. Woolas, J. Murdoch, S. Dobbs, S. Leeson, D. Cruickshank, E.-O. Fourkala, A. Ryan, M. Parmar, I. Jacobs, U. Menon, Risk of epithelial ovarian cancer in asymptomatic women with ultrasound-detected ovarian masses: A prospective cohort study within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Ultrasound Obstet. Gynecol. 40, 338-344 (2012).
39. C. A. Hamilton, M. K. Cheung, K. Osann, L. Chen, N. N. Teng, T. A. Longacre, M. A. Powell, M. R. Hendrickson, D. S. Kapp, J. K. Chan, Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers. Br. J. Cancer 94, 642-646 (2006).
40. M. Gerlinger, A. J. Rowan, S. Horswell, M. Math, J. Larkin, D. Endesfelder, E. Gronroos, P. Martinez, N. Matthews, A. Stewart, P. Tarpey, I. Varela, B. Phillimore, S. Begum, N. Q. McDonald, A. Butler, D. Jones, K. Raine, C. Latimer, C. R. Santos, M. Nohadani, A. C. Eklund, B. Spencer-Dene, G. Clark, L. Pickering, G. Stamp, M. Gore, Z. Szallasi, J. Downward, P. A. Futreal, C. Swanton, Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med. 366, 883-892 (2012).
41. M. M. AlHilli, S. C. Dowdy, A. L. Weaver, J. L. St Sauver, G. L. Keeney, A. Mariani, K. C. Podratz, J. N. Bakkum-Gamez, Incidence and factors associated with synchronous ovarian and endometrial cancer: A population-based case-control study. Gynecol. Oncol. 125, 109-113 (2012).
42. C. Walsh, C. Holschneider, Y. Hoang, K. Tieu, B. Karlan, I. Cass, Coexisting ovarian malignancy in young women with endometrial cancer. Obstet. Gynecol. 106, 693-699 (2005).
43. R. Zaino, C. Whitney, M. F. Brady, K. DeGeest, R. A. Burger, R. E. Buller, Simultaneously detected endometrial and ovarian carcinomas-A prospective clinicopathologic study of 74 cases: A gynecologic oncology group study. Gynecol. Oncol. 83, 355-362 (2001).
44. T. Song, S. J. Seong, D.-S. Bae, J.-H. Kim, D. H. Suh, K.-H. Lee, S. -Y. Park, T. S. Lee, Prognostic factors in women with synchronous endometrial and ovarian cancers. Int. J. Gynecol. Cancer 24, 520-527 (2014).
45. D. P. Steensma, R. Bejar, S. Jaiswal, R. C. Lindsley, M. A. Sekeres, R. P. Hasserjian, B. L. Ebert, Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. Blood 126, 9-16 (2015).
46. C. C. Coombs, A. Zehir, S. M. Devlin, A. Kishtagari, A. Syed, P. Jonsson, D. M. Hyman, D. B. Solit, M. E. Robson, J. Baselga, M. E. Arcila, M. Ladanyi, M. S. Tallman, R. L. Levine, M. F. Berger, Therapy-related clonal hematopoiesis in patients with non-hematologic cancers is common and associated with adverse clinical outcomes. Cell Stem Cell 21, 374-382.e4 (2017).
47. A. L. Young, G. A. Challen, B. M. Birmann, T. E. Druley, Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults. Nat. Commun. 7, 12484 (2016).
48. J. D. Krimmel, M. W. Schmitt, M. I. Harrell, K. J. Agnew, S. R. Kennedy, M. J. Emond, L. A. Loeb, E. M. Swisher, R. A. Risques, Ultra-deep sequencing detects ovarian cancer cells in peritoneal fluid and reveals somatic TP53 mutations in noncancerous tissues. Proc. Natl. Acad. Sci. U.S.A. 113, 6005-6010 (2016).
49. M. S. Anglesio, N. Papadopoulos, A. Ayhan, T. M. Nazeran, M. Noe, H. M. Horlings, A. Lum, S. Jones, J. Senz, T. Seckin, J. Ho, R.-C. Wu, V. Lac, H. Ogawa, B. Tessier-Cloutier, R. Alhassan, A. Wang, Y. Wang, J. D. Cohen, F. Wong, A. Hasanovic, N. Orr, M. Zhang, M. Popoli, W. McMahon, L. D. Wood, A. Mattox, C. Allaire, J. Segars, C. Williams, C. Tomasetti, N. Boyd, K. W. Kinzler, C. B. Gilks, L. Diaz, T.-L. Wang, B. Vogelstein, P. J. Yong, D. G. Huntsman, I.-M. Shih, Cancer-associated mutations in endometriosis without cancer. N. Engl. J. Med. 376, 1835-1848 (2017).
50. N. Nair, O. Camacho-Vanegas, D. Rykunov, M. Dashkoff, S. C. Camacho, C. A. Schumacher, J. C. Irish, T. T. Harkins, E. Freeman, I. Garcia, E. Pereira, S. Kendall, R. Belfer, T. Kalir, R. Sebra, B. Reva, P. Dottino, J. A. Martignetti, Genomic analysis of uterine lavage fluid detects early endometrial cancers and reveals a prevalent landscape of driver mutations in women without histopathologic evidence of cancer: A prospective cross-sectional study. PLOS Med. 13, e1002206 (2016).
51. R. G. Moore, A. K. Brown, M. C. Miller, S. Skates, W. J. Allard, T. Verch, M. Steinhoff, G. Messerlian, P. DiSilvestro, C. O. Granai, R. C. Bast Jr., The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass. Gynecol. Oncol. 108, 402-408 (2008).
52. C. Bettegowda, M. Sausen, R. J. Leary, I. Kinde, Y. Wang, N. Agrawal, B. R. Bartlett, H. Wang, B. Luber, R. M. Alani, E. S. Antonarakis, N. S. Azad, A. Bardelli, H. Brem, J. L. Cameron, C. C. Lee, L. A. Fecher, G. L. Gallia, P. Gibbs, D. Le, R. L. Giuntoli, M. Goggins, M. D. Hogarty, M. Holdhoff, S.-M. Hong, Y. Jiao, H. H. Juhl, J. J. Kim, G. Siravegna, D. A. Laheru, C. Lauricella, M. Lim, E. J. Lipson, S. K. N. Marie, G. J. Netto, K. S. Oliner, A. Olivi, L. Olsson, G. J. Riggins, A. Sartore-Bianchi, K. Schmidt, I.-M. Shih, S. M. Oba-Shinjo, S. Siena, D. Theodorescu, J. Tie, T. T. Harkins, S. Veronese, T.-L. Wang, J. D. Weingart, C. L. Wolfgang, L. D. Wood, D. Xing, R. H. Hruban, J. Wu, P. J. Allen, C. M. Schmidt, M. A. Choti, V. E. Velculescu, K. W. Kinzler, B. Vogelstein, N. Papadopoulos, L. A. Diaz Jr., Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci. Transl. Med. 6, 224ra24 (2014).
53. C. Rago, D. L. Huso, F. Diehl, B. Karim, G. Liu, N. Papadopoulos, Y. Samuels, V. E. Velculescu, B. Vogelstein, K. W. Kinzler, L. A. Diaz Jr., Serial assessment of human tumor burdens in mice by the analysis of circulating DNA. Cancer Res. 67, 9364-9370 (2007).
54. C. Douville, S. Springer, I. Kinde, J. D. Cohen, R. H. Hruban, A. M. Lennon, N. Papadopolous, K. W. Kinzler, B. Vogelstein, R. Karchin, Detection of aneuploidy in patients with cancer through amplification of long interspersed nucleotide elements (LINEs). Proc. Natl. Acad. Sci. U.S.A. 115, 1871-1876 (2018).
55. Y. Wang, K. Sundfeldt, C. Mateoiu, I.-M. Shih, R. J. Kurman, J. Schaefer, N. Silliman, I. Kinde, S. Springer, M. Foote, B. Kristjansdottir, N. James, K. W. Kinzler, N. Papadopoulos, L. A. Diaz, B. Vogelstein, Diagnostic potential of tumor DNA from ovarian cyst fluid. eLife 5, e15175 (2016).
56. S. A. Forbes, D. Beare, H. Boutselakis, S. Bamford, N. Bindal, J. Tate, C. G. Cole, S. Ward, E. Dawson, L. Ponting, R. Stefancsik, B. Harsha, C. Y. Kok, M. Jia, H. Jubb, Z. Sondka, S. Thompson, T. De, P. J. Campbell, COSMIC: Somatic cancer genetics at high-resolution. Nucleic Acids Res. 45, D777-D783 (2017).
57. H. Jung, D. Lee, J. Lee, D. Park, Y. J. Kim, W.-Y. Park, D. Hong, P. J. Park, E. Lee, Intron retention is a widespread mechanism of tumor-suppressor inactivation. Nat. Genet. 47, 1242-1248 (2015).